Clinical Trials Browser

Phase 2 × Advanced Biliary Tract Cancer × Nivolumab × Clear all

NCT04172402 2025-07-22

NGS as the First-line Treatment in Advanced Biliary Tract Cancer

Phase 2 Completed

Gastrointestinal

Advanced Biliary Tract Cancer